Evidence map›Paper›PMID 29740028›Full record

ArticleScientific reports2018

Novel antibiofilm chemotherapies target nitrogen from glutamate and glutamine.

Tal Hassanov, Iris Karunker, Nitai Steinberg, Ayelet Erez, Ilana Kolodkin-Gal

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 42 citations in OpenAlex.

  1. Global Transcriptional Differences inAntibiotics (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Microbiology spectrum · 2025
    Article
  4. Article
  5. Article
  6. The Utilization ofMicroorganisms · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Frontiers in microbiology · 2024
    Article
  11. Article
  12. Drug delivery strategies for antibiofilm therapy.Nature reviews. Microbiology · 2023
    Review
  13. Article
  14. Article
  15. Article
  16. Structural basis for the helical filament formation of Escherichia coli glutamine synthetase.Protein science : a publication of the Protein Society · 2022
    Article
  17. Frontiers in cellular and infection microbiology · 2021
    Article
  18. Review
  19. Article
  20. Microbial Metabolic Genes Crucial forFrontiers in microbiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Tal HassanovDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Iris KarunkerDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Nitai SteinbergDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Ayelet ErezDepartment of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.
Ilana Kolodkin-GalDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel. ilana.kolodkin-gal@weizmann.ac.il.
Weizmann Institute of Science · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacteria in nature often reside in differentiated communities termed biofilms, which are an active interphase between uni-cellular and multicellular life states for bacteria. Here we demonstrate that the development of B. subtilis biofilms is dependent on the use of glutamine or glutamate as a nitrogen source. We show a differential metabolic requirement within the biofilm; while glutamine is necessary for the dividing cells at the edges, the inner cell mass utilizes lactic acid. Our results indicate that biofilm cells preserve a short-term memory of glutamate metabolism. Finally, we establish that drugs that target glutamine and glutamate utilization restrict biofilm development. Overall, our work reveals a spatial regulation of nitrogen and carbon metabolism within the biofilm, which contributes to the fitness of bacterial complex communities. This acquired metabolic division of labor within biofilm can serve as a target for novel anti-biofilm chemotherapies.

Indexed as

Aminooxyacetic AcidAnti-Bacterial AgentsBacillus subtilisBacterial ProteinsBiofilmsCarbonDiazooxonorleucineGene Expression Regulation, BacterialGlutamic AcidGlutamineMutant ProteinsNitrogenRepressor ProteinsAminooxyacetic AcidAnti-Bacterial AgentsBacterial ProteinsCarbonDiazooxonorleucineGlutamic AcidGlutamineMutant ProteinsNitrogenRepressor ProteinsScgR protein, Bacillus subtilis

Identifiers

PMID29740028
PMCPMC5940852
OpenAlexW2801530566

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.